drugset / Trial / NCT00174317

Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip

NCT00174317

Phase 4 Completed 250 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine if celecoxib 200 mg once daily is as effective as diclofenac 50 mg three times daily in the treatment of pain symptoms associated with osteoarthritis of the hip

Timeline

Start
2003-08
Primary completion
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg
Subject Diclofenac Other / unclassified 50 mg

Indications